Latest Nephrology Stories
The Firm is representing individuals in GranuFlo lawsuits who suffered heart attacks, strokes, sudden cardiac death, and other serious heart events, allegedly due to the use of GranuFlo and NaturaLyte.
An aging US population and inelastic demand will drive industry growth.
This report studies the global dialysis products and services market over the forecast period of 2013 to 2018 -
In the United States, African Americans have approximately twice the risk of end-stage renal disease compared to white Americans, despite a similar prevalence in earlier stages of chronic kidney disease.
The Firm is evaluating GranuFlo lawsuits on behalf of individuals who allegedly suffered catastrophic heart problems associated with the GranuFlo recall for GranuFlo and NaturaLyte dialysis concentrates.
Guebert announces largest exhibit presence ever at Radiology Society of North America Annual Meeting Princeton, NJ (PRWEB) November 26, 2013 Guerbet
Hypertension is a peer-reviewed scientific journal established in 1979 and published monthly by the American Heart Association (AHA). As of May 2012, the editor-in-chief is John E. Hall (University of Mississippi). Publishing formats include original manuscripts, invited review summaries, invited case-based reviews, recent study highlights, invited brief commentaries, scientific or technical tutorials, letter to the editor, and novel findings of unusual interest. This journal focuses on...
- A trick or prank.